1 |
Fila M, Sobczuk A, Pawlowska E, Blasiak J. Epigenetic Connection of the Calcitonin Gene-Related Peptide and Its Potential in Migraine. Int J Mol Sci 2022;23:6151. [PMID: 35682830 DOI: 10.3390/ijms23116151] [Reference Citation Analysis]
|
2 |
Sabina S, Panico A, Mincarone P, Leo CG, Garbarino S, Grassi T, Bagordo F, De Donno A, Scoditti E, Tumolo MR. Expression and Biological Functions of miRNAs in Chronic Pain: A Review on Human Studies. Int J Mol Sci 2022;23:6016. [PMID: 35682695 DOI: 10.3390/ijms23116016] [Reference Citation Analysis]
|
3 |
Basedau H, Sturm LM, Mehnert J, Peng KP, Schellong M, May A. Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target - an fMRI study. Elife 2022;11:e77146. [PMID: 35604755 DOI: 10.7554/eLife.77146] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
Tesfay B, Karlsson WK, Moreno RD, Hay DL, Hougaard A. Is calcitonin gene-related peptide a reliable biochemical marker of migraine? Curr Opin Neurol 2022;35:343-52. [PMID: 35674078 DOI: 10.1097/WCO.0000000000001053] [Reference Citation Analysis]
|
5 |
Ferreira KS, Dhillon H, Velly AM. The role of a potential biomarker in patients with migraine: review and new insights. Expert Rev Neurother 2021;21:817-31. [PMID: 34210227 DOI: 10.1080/14737175.2021.1951236] [Reference Citation Analysis]
|
6 |
Nowaczewska M, Straburzyński M, Waliszewska-Prosół M, Meder G, Janiak-Kiszka J, Kaźmierczak W. Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine-A Real-Life Study. Front Neurol 2022;13:895476. [PMID: 35655615 DOI: 10.3389/fneur.2022.895476] [Reference Citation Analysis]
|
7 |
Harder AVE, Vijfhuizen LS, Henneman P, Willems van Dijk K, van Duijn CM, Terwindt GM, van den Maagdenberg AMJM. Metabolic profile changes in serum of migraine patients detected using 1H-NMR spectroscopy. J Headache Pain 2021;22:142. [PMID: 34819016 DOI: 10.1186/s10194-021-01357-w] [Reference Citation Analysis]
|
8 |
Baraldi C, Castro FL, Cainazzo MM, Pani L, Guerzoni S. Predictors of response to erenumab after 12 months of treatment. Brain Behav 2021;11:e2260. [PMID: 34268907 DOI: 10.1002/brb3.2260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|